Hybrid Coronary Revascularization Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT03089398
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Registry
-
NCT03089398
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT03089398. Randomized; single masking; primary purpose treatment. Start 2017-10-09 (actual); primary completion 2021-03-31 (actual). Results posted on 2025-05-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hybrid Coronary Revascularization Trial
- Condition
- Coronary Artery Disease
- Intervention (Procedure)
- Hybrid Coronary Revascularization (isolated LIMA-LAD)
- Intervention (Device)
- Hybrid Coronary Revascularization (PCI (percutaneous coronary intervention))
- Intervention (Device)
- Percutaneous Coronary Intervention
- Lead sponsor
- Emilia Bagiella
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct03089398- Content hash
52ac57a804630b42927127d0f60b6d5d6bcc5e03512e4c06c136b222a699f26f